A Form 4 filed on August 27, 2026 with the Securities and Exchange Commission discloses that Andrew Gundlach, a director of Welltower Inc. (NYSE:WELL), acquired shares of common stock across two trading days through two trust accounts for which Bleichroeder LP serves as registered investment adviser.
Key Highlights
- Four separate purchase transactions were reported, each involving 2,500 shares of Welltower common stock.
- August 25, 2026 purchases were executed at a weighted average price of $239.47 per share, with individual trade prices ranging from $239.27 to $239.50.
- August 26, 2026 purchases were executed at a weighted average price of $242.06 per share, with individual trade prices ranging from $241.59 to $242.59.
- Two trust accounts were involved: Ellen-Maria Gorrissen Trust I U/A Dated June 3, 1993 and Ellen-Maria Gorrissen Trust II U/A Dated June 3, 1993.
- Following the transactions, the filing reports beneficial ownership of 27,500 shares in Trust I and 30,000 shares in Trust II, held indirectly.
- Gundlach is identified as President and Chief Executive Officer of Bleichroeder LP, which serves as registered investment adviser to both trusts.
Welltower Director's Share Acquisitions Through Trust Accounts
According to the filing, Andrew Gundlach, listed as a director of Welltower Inc., a healthcare real estate investment trust, reported four open-market purchase transactions in Welltower common stock over two consecutive days. All transactions carried transaction code "P," indicating open-market purchases. Each of the four transactions involved 2,500 shares, with two transactions recorded on August 25, 2026 and two on August 26, 2026.
The filing identifies both acquiring entities as trusts for which Bleichroeder LP acts as registered investment adviser. Gundlach is disclosed as President and Chief Executive Officer of Bleichroeder LP and, in the case of Trust I, also as a beneficiary. The filing states that Gundlach, on his own behalf and on behalf of Bleichroeder LP, "disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein," and that the report "shall not be deemed an admission that either the reporting person or Bleichroeder LP is the beneficial owner of the securities for purposes of Section 16 or for any other purposes."
For the August 25 transactions, both executed at a weighted average of $239.47, the filing notes that individual trade prices ranged from $239.27 to $239.50. For the August 26 transactions, both executed at a weighted average of $242.06, trade prices ranged from $241.59 to $242.59. The filing was signed by Matthew McQueen as attorney-in-fact for Andrew Gundlach on August 27, 2026.
What Was Disclosed
The filing reports four purchases of Welltower common stock, 2,500 shares each, split between two trust accounts over August 25 and August 26, 2026. All ownership is reported as indirect, with Bleichroeder LP serving as investment adviser to both trusts.



Please wait processing your request...